Zelluna ASA: Invitation to Fourth Quarter 2025 Results Webcast Presentation

Oslo, Norway, 5 February 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of its fourth quarter 2025 results on Thursday, 12 February 2026.

The presentation can be followed live via a webcast link available on www.zelluna.com at 08:30 CET on Thursday, 12 February 2026. The webcast recording will remain available on the company’s website after the event, and participants will be able to submit questions during the presentation.

The quarterly report and presentation materials will be published on the company’s website at 07:00 CET on the same day.

For further information, please see www.zelluna.com or contact:

For further information, please contact:

Namir Hassan, CEO, Zelluna ASA
Email: [email protected]
Phone: +44 7720 687608

Geir Christian Melen, CFO, Zelluna ASA
Email: [email protected]
Phone: +47 913 02 965

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• Steelworkers back Canada holding the line on trade, call for a stronger response to protect Canadian jobs and industry
• Crypto Presale Guide: What $BULLSKI’s Published Ladder Actually Fixes